USA flag logo/image

An Official Website of the United States Government

Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failure

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R44DK085766
Solicitation Year:
2012
Solicitation Topic Code:
NIDDK
Solicitation Number:
PA11-096
Small Business Information
SENTIEN BIOTECHNOLOGIES, INC.
196 Boston Ave Medford, MA -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2012
Title: Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failure
Agency: HHS
Contract: 2R44DK085766-03
Award Amount: $773,285.00
 

Abstract:

DESCRIPTION (provided by applicant): The overall goal of this project is to design a clinical protocol for the operation and monitoring of a mesenchymal stem cell (MSC)-coated dialysis device for the treatment of acute renal failure (ARF) in dogs. The project specific aims are: (1) Biomarker-guided initiation of Sentinel therapy in an ARF dogs. (2) Execute a dose escalation trial of the Sentinel in ARF dogs. The deliverable of this completed project will be an IND-ready device therapy that will be advancingtowards a Phase I clinical study. PUBLIC HEALTH RELEVANCE: Sentien Biotechnologies, Inc. has developed a mesenchymal stem cell (MSC)-coated device that offers combinatorial therapeutic support to patients undergoing acute renal failure (ARF). Thedevice delivers MSC-derived secretions of anti-inflammatory and regenerative molecules directly into the bloodstream in a dynamic and sustained manner. We now plan to develop an effective clinical protocol for the device for ARF that captures the criticalcomponents of a administering a new drug, namely (i) initiation time, (i) dose, and (iii) duration of treatment that will enable human investigation.

Principal Investigator:

Arno W. Tilles
617-724-2953
arno.tilles@sentienbiotech.com

Business Contact:

Brian Miller
781-361-9031
brian.miller@sentienbiotech.com
Small Business Information at Submission:

SENTIEN BIOTECHNOLOGIES, INC.
196 Boston Ave Medford, MA -

EIN/Tax ID: 126378267
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No